Invention Grant
- Patent Title: Buprenorphine dosing regimens
-
Application No.: US15523986Application Date: 2015-11-06
-
Publication No.: US11000520B2Publication Date: 2021-05-11
- Inventor: Azmi Nasser , Celine M Laffont , Christian Heidbreder
- Applicant: Indivior UK Limited
- Applicant Address: GB Hull
- Assignee: Indivior UK Limited
- Current Assignee: Indivior UK Limited
- Current Assignee Address: GB Hull
- Agent Lisa E. Stahl; Kathryn Jones
- International Application: PCT/IB2015/002269 WO 20151106
- International Announcement: WO2016/071767 WO 20160512
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61K9/00 ; A61K47/22 ; A61K47/34
Abstract:
The disclosure provides a dosage regimen using sustained-release buprenorphine formulations to produce therapeutic levels of buprenorphine in patients for the treatment of pain or opioid use disorders.
Public/Granted literature
- US20170354653A1 BUPRENORPHINE DOSING REGIMENS Public/Granted day:2017-12-14
Information query
IPC分类:
